Ima Wealth, Inc. Crispr Therapeutics Ag Transaction History

Ima Wealth, Inc.

$458 Million
Q3 2024

A detailed history of Ima Wealth, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ima Wealth, Inc. holds 20,526 shares of CRSP stock, worth $843,002. This represents 0.21% of its overall portfolio holdings.

Number of Shares

20,526

Previous 23,448 12.46%

Holding current value

$843,002

Previous $1.27 Million 23.85%

% of portfolio

0.21%

Previous 0.57%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $130,379 - $183,355	-2,922 Reduced 12.46%	20,526 $964,000
Q2 2024 Jul 25, 2024	SELL	$51.17 - $68.18 $27,529 - $36,680	-538 Reduced 2.24%	23,448 $1.27 Million
Q1 2024 Apr 24, 2024	SELL	$60.67 - $89.12 $42,165 - $61,938	-695 Reduced 2.82%	23,986 $1.63 Million
Q4 2023 Feb 05, 2024	SELL	$38.62 - $72.18 $32,286 - $60,342	-836 Reduced 3.28%	24,681 $1.55 Million
Q3 2023 Nov 28, 2023	SELL	$45.39 - $59.0 $11,574 - $15,045	-255 Reduced 0.99%	25,517 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$43.47 - $67.77 $30,863 - $48,116	710 Added 2.83%	25,772 $1.45 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $23,329 - $31,932	-569 Reduced 2.22%	25,062 $1.13 Million
Q4 2022 Feb 15, 2023	SELL	$39.19 - $65.67 $40,640 - $68,099	-1,037 Reduced 3.89%	25,631 $1.04 Million
Q3 2022 Nov 15, 2022	SELL	$61.1 - $83.78 $74,969 - $102,798	-1,227 Reduced 4.4%	26,668 $1.74 Million
Q2 2022 Aug 18, 2022	SELL	$43.23 - $73.83 $3,631 - $6,201	-84 Reduced 0.3%	27,895 $1.7 Million
Q1 2022 Jun 13, 2022	BUY	$53.19 - $79.24 $176,963 - $263,631	3,327 Added 13.5%	27,979 $1.76 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $80,463 - $127,760	1,148 Added 4.88%	24,652 $1.87 Million
Q3 2021 Nov 03, 2021	BUY	$110.2 - $156.64 $24,354 - $34,617	221 Added 0.95%	23,504 $2.63 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $300,503 - $482,432	-2,980 Reduced 11.35%	23,283 $3.77 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $370,801 - $703,423	3,349 Added 14.62%	26,263 $3.2 Million
Q4 2020 Feb 08, 2021	SELL	$79.67 - $173.23 $71,065 - $154,521	-892 Reduced 3.75%	22,914 $3.51 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $1.13 Million - $1.45 Million	-14,447 Reduced 37.77%	23,806 $1.99 Million
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $3,503 - $6,920	-91 Reduced 0.24%	38,253 $2.81 Million
Q1 2020 Apr 14, 2020	BUY	$33.68 - $62.53 $1.29 Million - $2.4 Million	38,344 New	38,344 $1.63 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ima Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ima Wealth, Inc. with notifications on news.

Account